- CA$3.28bn
- CA$20.23bn
- CA$975.66m
- 53
- 67
- 70
- 68
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 10 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 463 | 497 | 583 | 733 | 838 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 444 | 455 | 590 | 696 | 799 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 279 | 300 | 390 | 368 | 502 |
Provision for Income Taxes | |||||
Net Income After Taxes | 206 | 224 | 293 | 270 | 372 |
Net Income Before Extraordinary Items | |||||
Net Income | 206 | 224 | 293 | 270 | 372 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 202 | 219 | 288 | 265 | 365 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.05 | 6.43 | 8.36 | 7.55 | 9.59 |
Dividends per Share |